Evolution of diabetes treatment guidelines (20162025) Between 2016 and 2025, diabetes treatment guidelines, particularly those from major organizations such as the American Diabetes Association (ADA), American College of Cardiology, and European Association for the Study of Diabetes, evolved significantly based on new therapies and the results of CV outcomes trials (CVOTs)
For weight management, medications like Wegovy (semaglutide 2.4mg) are restricted to specialist weight management services with specific eligibility criteria
Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo
3) and auROC (area under the Receiver Operating Characteristic curve
In SURPASS-3, all three tirzepatide doses delivered superior A1C and body weight reductions from baseline compared to titrated insulin degludec